tert-Butyl (1-(3,5-bis(4-(trifluoromethyl)phenyl)pyridin-4-yl)piperidin-4-yl)carbamate

Catalog No. :
ACZKPS925
CAS No. :
2065250-56-6
Molecular Formula :
C29H29F6N3O2
Molecular Weight :
565.56

IUPAC Name:tert-butyl (1-(3,5-bis(4-(trifluoromethyl)phenyl)pyridin-4-yl)piperidin-4-yl)carbamate

tert-Butyl (1-(3,5-bis(4-(trifluoromethyl)phenyl)pyridin-4-yl)piperidin-4-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$672.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (1-(3,5-bis(4-(trifluoromethyl)phenyl)pyridin-4-yl)piperidin-4-yl)carbamate
IUPAC Nametert-butyl (1-(3,5-bis(4-(trifluoromethyl)phenyl)pyridin-4-yl)piperidin-4-yl)carbamate
MDL No.MFCD29067462
Molecular FormulaC29H29F6N3O2
Molecular Weight565.56
SMILESO=C(NC1CCN(CC1)C2=C(C=NC=C2C3=CC=C(C=C3)C(F)(F)F)C4=CC=C(C=C4)C(F)(F)F)OC(C)(C)C
InChI KeyJAYIMOVZNGYPTI-UHFFFAOYSA-N
SynonymJAYIMOVZNGYPTI-UHFFFAOYSA-N;Carbamic acid, N-[1-[3,5-bis[4-(trifluoromethyl)phenyl]-4-pyridinyl]-4-piperidinyl]-, 1,1-dimethylethyl ester;3',5'-Bis-(4-trifluoromethyl-phenyl)-3,4,5,6-tetrahydro-2H-[1,4']bipyridinyl-4-yl]-carbamic acid tert-butyl ester
CAS No.2065250-56-6

Synthetic Route by SureRoute

1. ACZKPS925 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGBLC269 route compound structure diagram
    ACGBLC269128796-39-4 In Stock
  4. Then
  5. ACZKPS925 route product structure diagram
    ACZKPS9252065250-56-6
Inquiry

2. ACZKPS925 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGBLC269 route compound structure diagram
    ACGBLC269128796-39-4 In Stock
  4. Then
  5. ACZKPS925 route product structure diagram
    ACZKPS9252065250-56-6
Inquiry

Comments (0)